Statistics for Crinetics Pharmaceuticals (id:7810 CRNX)
Valuation metrics
Market cap
5.07B
Enterprise value
4.26B
Trailing P/E (ttm)
-15.19
Forward P/E
-14.18
PEG ratio
-14.18
Price/Sales (ttm)
4.88K
Price/Book (mrq)
5.31
Enterprise Value/Revenue
4.10K
Enterprise Value/EBITDA
-14.00
Overview
Shares outstanding
92.74M
Float
91.42M
Shares short
6.94M
% Held by insiders
0.02%
% Held by institutions
0.94%
Average volume (10 days)
749.81K
Average volume (90 days)
Price summary
52-Week low
30.87
52-Week high
62.53
52-Week change
43.26%
Beta
0.62
50-Day moving average
54.97
200-Day moving average
48.56
Dividends and splits
Forward annual dividend rate
Forward annual dividend yield
Trailing annual dividend rate
0.00%
Trailing annual dividend yield
0.00
5-Year annual dividend yield
Payout ratio
0.00
Dividend date
Ex-dividend date
Last split factor
2:1
Last split date
Financials
Fiscal yearFiscal year ends
December 31th, 2023
Most recent quarter (mrq)
September 30th, 2024
Profitability
Profit margin
0.00%
Operating margin
-29,525.22%
Operational effectiveness
Return on assets
-24.29%
Return on equity
-40.26%
Income statement
Revenue (ttm)
0.01
Revenue per share (ttm)
0.01
Quarterly revenue growth (yoy)
Gross profit (ttm)
0.00
EBITDA
-304,508,000.00
Net income to common (ttm)
-277,910,016.00
Diluted EPS (ttm)
-3.70
Quarterly earnings growth (yoy)
Balance sheet
Total cash (mrq)
862.67M
Total cash per share (mrq)
9.30
Total debt (mrq)
52.54M
Total Debt/Equity (mrq)
6.31
Current ratio (mrq)
1.64K%
Book value per share (mrq)
10.30
Cash flow
Cash flow statement
-199,811,008.00
Levered free cash flow (LFCF)
-115,199,376.00